Persistent Asset Partners »

Aprea Therapeutics shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Aprea Therapeutics (APRE) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Aprea Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aprea Therapeutics held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aprea Therapeutics by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.2k 12k 0.80

More positions owned by Persistent Asset Partners

Intel Corporation Call Option (INTC)
Kla Corp Com New Call Option (KLAC)
Nebius Group Shs Class A Call Option (NBIS)
Kodiak Sciences Call Option (KOD)
Novo-nordisk A S Adr Put Option (NVO)
Corning Incorporated Call Option (GLW)
Vaxcyte Call Option (PCVX)
Micron Technology Call Option (MU)
Monte Rosa Therapeutics Call Option (GLUE)
Robinhood Mkts Com Cl A (HOOD)
Arcus Biosciences Incorporated Call Option (RCUS)
Stmicroelectronics N V Ny Registry (STM)
Uniqure Nv SHS Call Option (QURE)
Amphenol Corp Cl A (APH)
Marvell Technology Call Option (MRVL)

View all positions for Persistent Asset Partners

Top funds holding Aprea Therapeutics

AIGH Capital Management
Vestal Point Capital
Sphera Funds Management
Nantahala Capital Management
Renaissance Technologies
Geode Capital Management
Citadel Advisors
Bnp Paribas Arbitrage, Snc
Diadema Partners
Vanguard Fiduciary Trust
Susquehanna International
Vanguard Capital Management
Morgan Stanley
LPL Financial
HighTower Advisors

View all funds holding Aprea Therapeutics